Swift Street Capital
Venture capitalActively deployingDurham · Seed–Series A · 2 people tracked
Investment thesis
Swift Street Capital is a physician-led venture firm focused on backing the next generation of life science startups emerging from top research universities. Led by physicians, the firm aims to support founders translating academic research into companies, positioning itself at the intersection of clinical expertise and university-driven innovation.
Source: firm website, verified Aug 3, 2026.
Team · 2 people
from the firm's websiteFrequently asked questions
- What stage does Swift Street Capital invest at?
- Swift Street Capital invests at the Seed, Series A stages.
- What sectors does Swift Street Capital focus on?
- Swift Street Capital focuses on AI & Machine Learning, Biotech, Digital Health, Healthtech, Longevity, Medical Devices.
- Where is Swift Street Capital located?
- Swift Street Capital is headquartered in Durham, US.
Images
Similar investors
Future Positive Capital is a European deep-tech fund that ties its entire thesis to the Future Cones foresight framework, explicitly focusing on preferable futures and positioning itself as a futures-thinking, systems-change VC rather than a generic climate or impact fund. The firm hard-wires impact into its economics by contractually indexing more than 100% of partners' carried interest to portfolio companies achieving both financial and measurable impact outcomes, while specializing in capital-intensive, highly technical step-change solutions for planetary-scale problems like robotics for wind farm operations, large-scale carbon removal, and ecosystem restoration.
GV (Google Ventures) is a venture capital firm that has invested in artificial intelligence and machine learning since its early days, building a global portfolio of more than 100 AI companies across infrastructure, life sciences, and applications.
Khosla Ventures is a venture capital firm that invests in early-stage companies focused on technology, mobile, and clean energy sectors, including biotechnology applications. The firm provides capital and strategic support to entrepreneurs developing breakthrough technologies across multiple markets.
Averin Capital is an investment firm focused on the intersection of technology and health, backing teams building companies in areas such as early disease detection, treatment delivery, personalized care, and medical breakthroughs.
Casdin Capital is an investment firm focused on the life sciences, investing across healthcare, biotechnology, synthetic biology, and related technology.






